CRMD CorMedix Inc.

8.57
+0.03  (+0%)
Previous Close 8.54
Open 8.5
Price To Book 15.04
Market Cap 247,313,873
Shares 28,842,277
Volume 15,915
Short Ratio 15.07
Av. Daily Volume 247,489

NewsSee all news

  1. CorMedix Inc. to Present at the H.C. Wainwright 21st Annual Global Investment Conference

    BERKELEY HEIGHTS, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Pre-NDA meeting with FDA 4Q 2019.
Neutrolin - LOCK-IT 100
Hemodialysis patients with central venous catheters
Phase 3 to be initiated pending funding.
Neutrolin - LOCK-IT 200
Oncology patients on Total Parental Nutrition (TPN)

Latest News

  1. CorMedix Inc. to Present at the H.C. Wainwright 21st Annual Global Investment Conference

    BERKELEY HEIGHTS, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of